The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...
British doctors who assessed PET-CT scans, which help diagnose and stage cancers, discovered the jabs detrimentally affected how tissue appeared on scans.